Ortho-McNeil-Janssen Pharmaceutica Inc | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Ortho-McNeil-Janssen Pharmaceutica Inc

Sort by

Viewing results 1‒7 of 7

Covid-19 vaccines
J&J seeks US authorisation for Covid-19 vaccine
FDA will now weigh whether to allow use of first single-dose jab to prevent the virus
February 4, 2021
Johnson & Johnson Co Inc
Johnson & Johnson to buy biotech Momenta in $6.5bn deal
...The deal will give J&J’s drugmaking division Janssen Pharmaceutica access to Momenta’s pipeline of products, including nipocalimab, a promising treatment for the rare muscular disease myasthenia gravis that...
August 19, 2020
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
Brexit
Big pharma say Britain must continue to attract top scientists
GSK and MSD among 25 companies included in government’s £1bn ‘sector deal’
December 6, 2017
US & Canadian companies
Sweeteners, incentives – and abundant water supplies – help draw multinationals to Wallonia
...A European distribution centre opened in 2012 by Janssen Pharmaceutica (part of the multinational Johnson & Johnson) met all of the criteria set by the regional government and received €11m out of a total...
November 5, 2014
beyondbricsJonathan Wheatley
Redesigning healthcare in Africa
...They are contained in a report published on Thursday, The future of healthcare in Africa, commissioned by Janssen Pharmaceutica, a Belgian subsidiary of Johnson & Johnson of the US....
March 1, 2012
Mergers & Acquisitions
J&J plaintiffs shrug off report
...one of several US legal actions related to marketing of its products, the report describes a “doctor for a day” programme used until 2003 that was developed by the sales force and “not …management” of Ortho-McNeil...
July 24, 2011
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
US downturn
Wall Street rally led by blue chips
...Isis Pharmaceuticals rose 4.2 per cent to $13.30 after it announced a collaboration with Ortho-McNeil, a unit of Johnson & Johnson , up 1 per cent at $63.11, for the treatment of various medical disorders...
September 13, 2007

Previous pagePage 1 of 1Next page